Pervasis Therapeutics

company

About

Pervasis Therapeutics is a clinical stage company offering a broad portfolio of biologically active therapeutics.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$9.75M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9.75M
Pervasis Therapeutics has raised a total of $9.75M in funding over 2 rounds. Their latest funding was raised on Jan 15, 2008 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 15, 2008 Series Unknown $9.75M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Pervasis Therapeutics is funded by 1 investors. Musket Research Associates are the most recent investors.
Investor Name Lead Investor Funding Round
Musket Research Associates Series Unknown